Literature DB >> 22689978

Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo.

Janine Gotot1, Catherine Gottschalk, Sonny Leopold, Percy A Knolle, Hideo Yagita, Christian Kurts, Isis Ludwig-Portugall.   

Abstract

The mechanisms by which regulatory T cells (T(regs)) suppress autoantibody production are unclear. Here we have addressed this question using transgenic mice expressing model antigens in the kidney. We report that T(regs) were essential and sufficient to suppress autoreactive B cells in an antigen-specific manner and to prevent them from producing autoantibodies. Most of this suppression was mediated through the inhibitory cell-surface-molecule programmed death-1 (PD-1). Suppression required PD-1 expression on autoreactive B cells and expression of the two PD-1 ligands on T(regs). PD-1 ligation inhibited activation of autoreactive B cells, suppressed their proliferation, and induced their apoptosis. Intermediate PD-1(+) cells, such as T helper cells, were dispensable for suppression. These findings demonstrate in vivo that T(regs) use PD-1 ligands to directly suppress autoreactive B cells, and they identify a previously undescribed peripheral B-cell tolerance mechanism against tissue autoantigens.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22689978      PMCID: PMC3387068          DOI: 10.1073/pnas.1201131109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

Review 1.  Negative co-receptors on lymphocytes.

Authors:  Rebecca J Greenwald; Yvette E Latchman; Arlene H Sharpe
Journal:  Curr Opin Immunol       Date:  2002-06       Impact factor: 7.486

2.  The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells.

Authors:  Su-jean Seo; Michele L Fields; Jodi L Buckler; Amy J Reed; Laura Mandik-Nayak; Simone A Nish; Randolph J Noelle; Laurence A Turka; Fred D Finkelman; Andrew J Caton; Jan Erikson
Journal:  Immunity       Date:  2002-04       Impact factor: 31.745

3.  PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.

Authors:  T Okazaki; A Maeda; H Nishimura; T Kurosaki; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

4.  CD4+CD25+ T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner.

Authors:  Wim Janssens; Vincent Carlier; Bo Wu; Luc VanderElst; Marc G Jacquemin; Jean-Marie R Saint-Remy
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

5.  CD4+CD25+ regulatory cells from human peripheral blood express very high levels of CD25 ex vivo.

Authors:  Clare Baecher-Allan; Julia A Brown; Gordon J Freeman; David A Hafler
Journal:  Novartis Found Symp       Date:  2003

6.  Treg cells: patrolling a dangerous neighborhood.

Authors:  Daniel J Campbell; Meghan A Koch
Journal:  Nat Med       Date:  2011-08-04       Impact factor: 53.440

7.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.

Authors:  B Salomon; D J Lenschow; L Rhee; N Ashourian; B Singh; A Sharpe; J A Bluestone
Journal:  Immunity       Date:  2000-04       Impact factor: 31.745

8.  PD-L2 is a second ligand for PD-1 and inhibits T cell activation.

Authors:  Y Latchman; C R Wood; T Chernova; D Chaudhary; M Borde; I Chernova; Y Iwai; A J Long; J A Brown; R Nunes; E A Greenfield; K Bourque; V A Boussiotis; L L Carter; B M Carreno; N Malenkovich; H Nishimura; T Okazaki; T Honjo; A H Sharpe; G J Freeman
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

9.  Expression of programmed death 1 ligands by murine T cells and APC.

Authors:  Tomohide Yamazaki; Hisaya Akiba; Hideyuki Iwai; Hironori Matsuda; Mami Aoki; Yuka Tanno; Tahiro Shin; Haruo Tsuchiya; Drew M Pardoll; Ko Okumura; Miyuki Azuma; Hideo Yagita
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

10.  B cells and professional APCs recruit regulatory T cells via CCL4.

Authors:  R S Bystry; V Aluvihare; K A Welch; M Kallikourdis; A G Betz
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

View more
  45 in total

Review 1.  Regulatory T cells and B cells: implication on autoimmune diseases.

Authors:  Ping Wang; Song Guo Zheng
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

2.  Batf3-dependent dendritic cells in the renal lymph node induce tolerance against circulating antigens.

Authors:  Catherine Gottschalk; Vera Damuzzo; Janine Gotot; Richard A Kroczek; Hideo Yagita; Kenneth M Murphy; Percy A Knolle; Isis Ludwig-Portugall; Christian Kurts
Journal:  J Am Soc Nephrol       Date:  2013-02-14       Impact factor: 10.121

3.  The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model.

Authors:  M Yuksel; X Xiao; N Tai; Manakkat Vijay; E Gülden; K Beland; P Lapierre; F Alvarez; Z Hu; I Colle; Y Ma; L Wen
Journal:  Clin Exp Immunol       Date:  2016-08-23       Impact factor: 4.330

4.  Both PD-1 ligands protect the kidney from ischemia reperfusion injury.

Authors:  Katarzyna Jaworska; Joanna Ratajczak; Liping Huang; Kristen Whalen; Mana Yang; Brian K Stevens; Gilbert R Kinsey
Journal:  J Immunol       Date:  2014-11-17       Impact factor: 5.422

5.  Targeting Antigen-Specific B Cells Using Antigen-Expressing Transduced Regulatory T Cells.

Authors:  Ai-Hong Zhang; Jeongheon Yoon; Yong Chan Kim; David W Scott
Journal:  J Immunol       Date:  2018-07-18       Impact factor: 5.422

Review 6.  Clinical blockade of PD1 and LAG3--potential mechanisms of action.

Authors:  Linh T Nguyen; Pamela S Ohashi
Journal:  Nat Rev Immunol       Date:  2015-01       Impact factor: 53.106

Review 7.  Manipulating the PD-1 pathway to improve immunity.

Authors:  Alice O Kamphorst; Rafi Ahmed
Journal:  Curr Opin Immunol       Date:  2013-04-09       Impact factor: 7.486

Review 8.  Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2020-08-24       Impact factor: 3.199

9.  Inhibitor of NFκB Kinase Subunit 2 Blockade Hinders the Initiation but Aggravates the Progression of Crescentic GN.

Authors:  Janine Gotot; Eveline Piotrowski; Martin S Otte; André P Tittel; Guo Linlin; Chen Yao; Karl Ziegelbauer; Ulf Panzer; Natalio Garbi; Christian Kurts; Friedrich Thaiss
Journal:  J Am Soc Nephrol       Date:  2015-11-16       Impact factor: 10.121

Review 10.  Re-educating immunity in respiratory allergies: the potential for hematopoietic stem cell-mediated gene therapy.

Authors:  Jeremy F Brooks; Janet M Davies; James W Wells; Raymond J Steptoe
Journal:  J Mol Med (Berl)       Date:  2017-11-17       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.